NicOx Shares Fall Most In 5 Years On Study Failure

Tuesday, May 6, 2008

Comments

Bloomberg

May 6 (Bloomberg) -- NicOx SA, the French drugmaker developing treatments with Pfizer Inc. and Merck & Co., fell the most in five years in Paris trading after an experimental glaucoma medicine failed in a mid-stage study.

Full Story

Glaucoma Testing Equipment / Glaucoma Products »

The patient depicted in the photograph below would be best treated with:
1. Acetylcysteine 10% drops
2. Prednisolone drops
3. Sodium cromolyn drops
4. Olopatadine drops
Check The Answer

3nethra classic Ophthalmic Imaging Device
The 3nethra classic is a compact, ... view product
SPECTRALIS Diagnostic Imaging Platform
A modular and upgradeable ophthalmic ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

NicOx Shares Fall Most In 5 Years On Study Failure

Comments

Related Categories

Glaucoma Testing Equipment / Glaucoma Products »

Quick Quiz

The patient depicted in the photograph below would be best treated with:

AdGlare RMR Ad

Featured Products

3nethra classic Ophthalmic Imaging Device

SPECTRALIS Diagnostic Imaging Platform

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us